Stylianou, C.; Kalemikerakis, I.; Konstantinidis, T.; Kafazi, A.; Alevizopoulos, N.; Parissopoulos, S.; Govina, O.
Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy. Medicina 2024, 60, 1845.
https://doi.org/10.3390/medicina60111845
AMA Style
Stylianou C, Kalemikerakis I, Konstantinidis T, Kafazi A, Alevizopoulos N, Parissopoulos S, Govina O.
Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy. Medicina. 2024; 60(11):1845.
https://doi.org/10.3390/medicina60111845
Chicago/Turabian Style
Stylianou, Christos, Ioannis Kalemikerakis, Theocharis Konstantinidis, Alkmena Kafazi, Nektarios Alevizopoulos, Stelios Parissopoulos, and Ourania Govina.
2024. "Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy" Medicina 60, no. 11: 1845.
https://doi.org/10.3390/medicina60111845
APA Style
Stylianou, C., Kalemikerakis, I., Konstantinidis, T., Kafazi, A., Alevizopoulos, N., Parissopoulos, S., & Govina, O.
(2024). Quality of Life and Symptom Burden in Non-Small-Cell Lung Cancer Patients Receiving Second-Line Chemotherapy Compared with Immunotherapy. Medicina, 60(11), 1845.
https://doi.org/10.3390/medicina60111845
